Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.380
+0.135 (3.18%)
At close: Jun 6, 2025, 4:00 PM
4.360
-0.020 (-0.46%)
After-hours: Jun 6, 2025, 4:00 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $18.60 million as of June 6, 2025. Its market cap has increased by 283.53% in one year.
Market Cap
18.60M
Enterprise Value
13.59M
1-Year Change
283.53%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $18.60M, a decrease of -71.07%. That is a compound annual growth rate of -29.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2025 | 18.00M | 10.59% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.62B |
| Johnson & Johnson | 367.79B |
| AbbVie | 328.34B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 273.05B |
| Abbott Laboratories | 230.53B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |